intern
travel
increas
risk
exposur
ill
infecti
diseas
caus
bacteria
virus
parasit
nurs
practition
primari
emerg
care
set
work
knowledg
common
infecti
diseas
found
intern
destin
import
maintain
high
degre
suspicion
infecti
caus
examin
patient
travel
common
complaint
need
refer
patient
travel
health
clinic
infecti
diseas
specialist
pretravel
consult
posttravel
red
flag
import
consider
practic
u
nite
state
resid
travel
abroad
million
time
annual
locat
visit
travel
come
contact
unfamiliar
infecti
agent
nurs
practition
np
consult
patient
need
understand
ill
circul
destin
patient
trip
season
variat
local
resist
alter
pretravel
recommend
provid
choic
medic
treatment
methodolog
use
ill
addit
spread
infecti
diseas
previous
seen
develop
countri
commonli
visit
tourist
region
caribbean
rais
level
suspicion
tropic
infecti
agent
travel
pretravel
consult
includ
extens
discuss
food
water
insect
precaut
explor
patient
medic
histori
anticip
destin
activ
plan
assess
accomplish
vaccin
reduc
risk
infecti
diseas
recommend
medic
prescrib
prevent
treat
common
ill
experienc
intern
travel
ideal
pretravel
consult
occur
least
week
travel
allow
time
full
vaccin
efficaci
sever
import
compon
pretravel
consult
extens
review
travel
medic
histori
includ
childhood
ill
immun
complet
period
resurg
childhood
ill
measl
known
occur
countri
typic
cautionari
list
travel
destin
medic
histori
includ
cancer
immun
dysfunct
cardiac
respiratori
diseas
organ
bone
marrow
transplant
hematolog
disord
seriou
condit
may
requir
modif
travel
plan
alter
vaccin
recommend
exampl
travel
plan
summit
kilimanjaro
visit
cuzco
cardiac
respiratori
hematolog
histori
may
make
itinerari
illadvis
issu
altitud
ill
although
fulli
predict
often
sever
known
cardiovascular
respiratori
hematolog
disord
pregnanc
lactat
seriou
condit
requir
close
monitor
may
make
rustic
environ
inadvis
import
explor
activ
purpos
patient
trip
note
patient
stay
aircondit
hotel
versu
openair
accommod
urban
versu
rural
set
particip
highaltitud
adventur
travel
patient
anticip
adventur
travel
rabiesendem
area
may
requir
preexposur
vaccin
accommod
indic
increas
risk
vectorborn
diseas
malaria
dengu
chikungunya
tickborn
encephalopathi
japanes
enceph
je
rural
remot
destin
increas
need
heighten
food
water
vigil
prevent
foodborn
ill
countryand
regionspecif
recommend
must
also
consid
travel
mening
belt
subsaharan
africa
advis
receiv
mening
vaccin
pilgrim
travel
saudi
arabia
hajj
umrah
destin
inform
guid
provis
appropri
antibiot
selfadministr
patient
experi
travel
diarrhea
abroad
quinolon
thought
primari
medic
use
empir
treatment
uncompl
travel
diarrhea
longer
effect
region
southeast
asia
caribbean
relat
resist
pattern
camplyobact
cholera
isol
prophylact
antimalari
medic
choic
driven
distribut
plasmodium
strain
found
destin
chloroquin
resist
common
mani
part
world
make
standard
care
ineffect
multipl
local
presenc
chloroquineresist
strain
malaria
doxycyclin
atovaquoneproguanil
mefloquin
could
use
aid
malaria
prevent
medic
side
effect
profil
weigh
patient
histori
current
medic
regimen
offer
best
prescrib
match
travel
develop
countri
low
level
commun
access
insid
toilet
facil
plumb
clean
run
water
reliabl
refriger
place
travel
high
risk
foodborn
ill
cholera
risk
reduct
strategi
contamin
avoid
increas
vigil
recommend
food
destin
divid
high
intermedi
lower
risk
foodborn
ill
highrisk
destin
includ
asia
middl
east
africa
mexico
central
america
south
america
eastern
europ
south
africa
caribbean
island
consid
intermediaterisk
destin
industri
destin
us
canada
australia
new
zealand
japan
northern
western
europ
consid
low
risk
highrisk
food
serv
moist
room
temperatur
unpeel
raw
fruit
veget
salad
green
berri
unpasteur
dairi
undercook
meat
seafood
lowerrisk
food
includ
dri
product
bread
selfprepar
food
made
potabl
water
bottl
water
carbon
drink
buffetstyl
food
reconstitut
juic
food
prepar
serv
street
vendor
avoid
use
mnemon
devic
like
boil
cook
peel
forget
educ
travel
risk
consum
undercook
produc
dairi
meat
travel
avoid
nonpot
water
sourc
tap
water
ice
fountain
drink
beer
soda
tap
water
hotel
sink
shower
recommend
hand
wash
alcoholbas
hand
sanit
meal
food
handl
reduc
risk
pathogen
ingest
vectorborn
diseas
account
infecti
diseas
worldwid
result
death
annual
mosquito
fli
flea
triatomin
bug
freshwat
aquat
snail
vector
known
spread
diseas
human
yellow
fever
yf
malaria
dengu
fever
chikungunya
fever
je
west
nile
viru
spread
bite
mosquito
tick
transmit
lyme
diseas
tularemia
rocki
mountain
spot
fever
rickettsi
diseas
ehrlichiosi
newli
identifi
heartland
viru
fli
spread
leishmaniasi
onchocerciasi
river
blind
african
trypanosomiasi
african
sleep
sick
triatomin
bug
implic
spread
american
trypanosomiasi
chaga
diseas
flea
implic
vector
bubon
plagu
freshwat
aquat
snail
spread
diseas
schistosomiasi
although
vaccin
exist
vectorborn
diseas
yf
je
mani
diseas
none
other
tickborn
enceph
vaccin
avail
outsid
us
make
vaccin
impract
leisur
travel
prevent
vectorborn
diseas
includ
avoid
atrisk
area
behavior
coupl
consist
insecticid
repel
use
instruct
travel
avoid
wade
freshwat
river
lake
stream
prevent
contact
waterborn
infecti
agent
travel
sleep
adob
brick
palm
thatch
hut
south
america
lessen
exposur
triatomin
bug
associ
chaga
diseas
travel
taught
wear
long
sleev
woven
shirt
long
pant
hat
provid
barrier
sting
bite
insect
precautionari
measur
includ
treat
cloth
permethrin
repel
appli
insecticid
skin
center
diseas
control
prevent
cdc
recommend
use
insecticid
contain
deet
picaridin
oil
lemon
eucalyptu
aid
insect
bite
reduct
sleep
air
condit
avoid
outsid
activ
dusk
dawn
decreas
likelihood
exposur
malari
mosquito
air
condit
avail
malaria
risk
area
travel
sleep
permethrintr
mosquito
net
use
tight
screen
window
sleep
area
malaria
caus
plasmodium
speci
parasit
spread
via
bite
infect
femal
anophel
mosquito
estim
peopl
die
malaria
worldwid
disproportion
impact
children
subsaharan
africa
us
approxim
case
malaria
identifi
annual
outbreak
local
transmit
malaria
occur
us
outbreak
brought
us
intern
travel
infect
abroad
allow
parasit
transfer
new
local
person
mosquito
bite
malaria
also
spread
mother
unborn
child
share
use
needl
blood
transfus
organ
transplant
symptom
infect
gener
occur
day
week
infect
although
report
symptom
earli
day
postinfect
year
later
plasmodium
vivax
plasmodium
oval
remit
exacerb
symptomatolog
complic
diagnosi
symptom
malaria
includ
fever
chill
malais
nausea
vomit
diarrhea
myalgia
back
pain
headach
anemia
jaundic
neurolog
chang
includ
dizzi
confus
coma
lead
death
properli
identifi
treat
plasmodium
falciparum
plasmodium
knowlesi
consid
lethal
known
human
plasmodium
speci
rapid
progress
ill
pattern
quickli
deterior
neurolog
symptom
death
determin
speci
drug
suscept
narrow
via
evalu
travel
destin
p
falciparum
plasmodium
malari
distribut
worldwid
tropic
subtrop
region
p
vivax
predominantli
asia
latin
america
limitedli
africa
p
oval
found
primarili
west
africa
island
western
pacif
p
knowlesi
identifi
southeast
asia
malaysia
confirmatori
test
need
appropri
treatment
regimen
initi
determin
treatment
approach
malaria
follow
stepwis
approach
proper
identif
infect
plasmodium
speci
patient
clinic
statu
plasmodium
drug
suscept
malaria
identifi
via
use
thick
thin
blood
smear
stain
interpret
smear
need
perform
immedi
collect
clinician
familiar
malaria
one
neg
blood
smear
preclud
diagnosi
malaria
rather
repeat
smear
complet
everi
hour
total
set
three
set
smear
prepar
read
qualifi
technologist
read
neg
diagnosi
malaria
rule
plasmodium
identifi
stain
smear
parasit
densiti
estim
via
microscopi
polymeras
chain
reaction
test
done
final
determin
speci
drug
resist
cdc
perform
test
offer
treatment
regimen
case
malaria
diagnos
us
dengu
fever
dengu
fever
caus
singlestrand
rna
flaviviru
transmit
human
bite
aed
aegypti
mosquito
primarili
lesser
degre
aed
albopictu
aed
polynesiensi
aed
scutellari
mosquito
dengu
viru
denv
four
distinct
serotyp
identifi
wide
spectrum
clinic
symptomatolog
denv
common
arboviru
estim
million
infect
annual
worldwid
denv
identifi
africa
asia
america
caribbean
denv
symptom
rang
asymptomat
infect
sever
diseas
shock
hemorrhag
symptom
includ
fever
myalgia
arthralgia
retroorbit
pain
nausea
vomit
abdomin
pain
rash
posit
petechia
via
tourniquet
test
laboratori
abnorm
leukopenia
increas
hematocrit
rapid
decreas
platelet
count
denv
progress
sever
organ
impair
shock
hemorrhag
fluid
accumul
respiratori
distress
mani
case
denv
go
unreport
undiagnos
often
occur
region
malaria
also
endem
denv
vaccin
cur
treatment
regimen
support
care
symptom
manag
patient
travel
malariaendem
region
malaria
rule
caus
intern
acquir
ill
must
explor
even
malaria
confirm
coinfect
denv
chikungunya
viru
chikv
exclud
without
diagnost
test
chikungunya
fever
chikungunya
fever
caus
alphaviru
transmit
human
via
bite
aegypti
albopictu
mosquito
chikv
infect
begin
vagu
complaint
febril
ill
fatigu
headach
nausea
vomit
muscl
pain
rash
characterist
often
differenti
chikv
symptom
denv
sever
persist
joint
pain
hemorrhag
symptomatolog
note
chikv
infect
rare
fatal
treatment
focus
support
care
symptom
manag
chikv
identifi
africa
asia
america
caribbean
denv
chikv
infect
often
mistaken
commonli
overlook
malaria
symptom
appear
day
infect
typic
occur
within
day
chikv
confer
lifelong
immun
reinfect
regardless
symptomatolog
work
knowledg
vaccin
imper
provid
care
intern
travel
use
cdc
travel
web
site
review
vaccin
gener
recommend
particular
destin
although
help
web
site
view
final
word
vaccin
recommend
particular
patient
particular
destin
develop
plan
care
base
review
commonli
circul
ill
patient
medic
vaccin
histori
knowledg
contraind
vaccin
medic
suggest
np
primari
care
nuanc
prescrib
mani
destin
trigger
referr
travel
health
clinic
travel
health
clinic
provid
consult
intern
travel
valuabl
resourc
continuum
care
patient
patient
travel
includ
countri
requir
yf
vaccin
referr
certifi
yf
clinic
necessari
live
vaccin
would
contraind
patient
medic
histori
immun
systemealt
condit
patient
age
immun
respons
vaccin
may
diminish
requir
modif
vaccin
plan
multipl
live
vaccin
given
day
separ
approxim
week
provid
best
immun
respons
live
vaccin
inactiv
vaccin
may
administ
day
later
day
without
impact
immun
respons
yf
yf
caus
flaviviru
spread
via
bite
infect
femal
aegypti
mosquito
yf
current
isol
region
africa
south
america
symptom
yf
begin
day
infect
includ
fever
chill
headach
myalgia
may
progress
jaundic
hemorrhag
complic
shock
multisystem
organ
failur
death
proof
vaccin
entri
requir
mani
countri
requir
offici
yf
document
provid
certifi
yf
clinic
yf
live
vaccin
given
pregnant
women
children
age
month
anyon
immunealt
condit
allergi
egg
chicken
protein
gelatin
addit
condit
digeorg
syndrom
myasthenia
gravi
thymoma
surgic
remov
thymu
absolut
contraind
vaccin
patient
year
age
age
month
special
consider
true
risk
diseas
area
need
weigh
potenti
complic
vaccin
uncommon
risk
diseas
much
differ
entri
requir
document
specif
countri
patient
found
inappropri
vaccin
yf
clinic
issu
defer
certif
np
primari
care
refer
patient
travel
africa
south
america
yf
clinic
evalu
potenti
need
vaccin
document
yf
defer
statu
addit
patient
trip
take
yf
countri
even
airplan
layov
stop
vaccin
document
may
requir
yf
clinic
make
determin
vaccin
document
need
provid
necessari
certif
travel
yf
certif
document
valid
year
date
issu
list
yf
clinic
found
cdc
web
site
typhoid
fever
typhoid
fever
tf
bacteri
ill
caus
salmonella
typhi
ingest
food
water
contamin
fece
via
either
food
handl
infect
carrier
direct
inocul
common
rout
estim
million
peopl
contract
tf
worldwid
die
diseas
annual
infect
approxim
becom
chronic
carrier
asymptomat
yet
capabl
spread
diseas
tf
endem
develop
countri
worldwid
common
industri
nation
us
canada
western
europ
australia
japan
symptom
tf
includ
fever
c
weak
abdomin
pain
headach
anorexia
case
rosecolor
spot
rash
tf
definit
diagnos
via
blood
stool
sampl
presenc
typhi
vaccin
avail
live
oral
inactiv
inject
form
give
live
oral
form
children
younger
year
old
person
immunealt
condit
seriou
gastrointestin
diseas
activ
nausea
vomit
patient
oral
antibiot
oral
typhoid
vaccin
given
without
consider
space
live
vaccin
patient
take
live
oral
vaccin
four
capsul
one
capsul
taken
mouth
everi
day
empti
stomach
full
glass
water
booster
recommend
everi
year
exposur
typhu
continu
inactiv
vaccin
given
one
inject
booster
recommend
everi
year
exposur
typhu
continu
measl
mump
rubella
measl
outbreak
occur
worldwid
recent
outbreak
us
philippin
europ
brazil
cdc
report
record
number
us
measl
case
report
januari
june
unvaccin
underimmun
person
travel
abroad
frequent
transport
measl
vaccin
prevent
diseas
us
visit
area
ill
common
measl
highli
contagi
easili
spread
via
respiratori
tract
person
anoth
symptom
typic
occur
day
exposur
gener
present
mild
moder
fever
cough
sore
throat
runni
nose
conjunct
three
five
day
earli
symptom
first
appear
blotchi
rash
high
fever
occur
often
accompani
increas
malais
koplik
spot
mouth
throat
rash
typic
begin
hairlin
spread
downward
neck
trunk
arm
leg
feet
fever
subsid
rash
fade
person
measl
contagi
approxim
day
day
rash
appear
advis
intern
travel
transit
countri
current
outbreak
verifi
immun
via
titer
receiv
booster
measl
vaccin
contraind
addit
aforement
inactiv
typhoid
vaccin
vaccin
may
recommend
base
travel
itinerari
although
mani
vaccin
also
given
us
matter
routin
primari
care
understand
increas
risk
travel
necessit
care
review
vaccin
histori
hepat
hepat
rna
picornaviru
spread
via
fecalor
rout
much
typhi
accord
cdc
hepat
common
vaccineprevent
infect
acquir
intern
travel
viru
infect
liver
caus
symptom
abdomin
pain
anorexia
nausea
dark
urin
claycolor
stool
jaundic
occasion
rash
joint
pain
also
present
infant
young
children
hepat
infect
often
asymptomat
person
infect
hepat
viru
may
contagi
week
exhibit
symptom
ill
remain
contagi
symptom
resolv
incub
period
averag
day
rang
day
symptom
appear
ill
rang
mild
symptom
week
sever
ill
last
sever
month
hepat
vaccin
seri
consist
two
inject
given
month
year
apart
pediatr
adult
formul
avail
first
dose
provid
coverag
month
final
dose
given
full
vaccin
believ
confer
lifelong
immun
combin
hepat
b
vaccin
also
avail
hepat
b
partial
doublestrand
dna
viru
hepadnavirida
famili
spread
via
contamin
bodi
fluid
recommend
vaccin
travel
hepat
beendem
countri
anticip
medic
dental
procedur
tattoo
pierc
acupunctur
unprotect
sexual
activ
incub
hepat
b
rang
day
averag
incub
day
viru
infect
liver
caus
abdomin
pain
anorexia
nausea
dark
urin
claycolor
stool
jaundic
occasion
rash
joint
pain
also
present
infant
young
children
hepat
b
infect
often
asymptomat
serolog
test
necessari
determin
hepat
viru
respons
patient
symptom
order
determin
plan
care
hepat
b
identifi
serolog
marker
determin
patient
acut
resolv
chronic
infect
state
chronic
hepat
b
infect
place
patient
increas
risk
liver
cirrhosi
liver
cancer
hepat
b
vaccin
seri
given
three
dose
second
dose
given
month
first
final
dose
given
month
first
dose
full
vaccin
believ
confer
lifelong
immun
je
je
caus
flaviviru
spread
via
bite
infect
culex
mosquito
je
lead
caus
vaccineprevent
enceph
asia
wwwnpjournalorg
journal
nurs
practition
jnp
western
pacif
infect
person
experi
either
mild
symptom
symptom
typic
occur
day
infect
patient
sever
diseas
sudden
onset
fever
chill
fatigu
headach
malais
nausea
vomit
progress
quickli
seizur
coma
paralysi
death
neurolog
chang
je
mistaken
parkinsonianlik
featur
masklik
faci
tremor
cogwheel
rigid
well
poliomyelitislik
acut
flaccid
paralysi
je
diagnos
examin
cerebrospin
fluid
detect
viru
specif
immunoglobulin
antibodi
je
antibodi
detect
day
ill
onset
persist
day
polio
polio
caus
rna
picornaviru
spread
fecalor
rout
person
person
via
oral
secret
three
known
serotyp
polioviru
mean
infect
serotyp
provid
immun
serotyp
approxim
person
infect
polio
asymptomat
spread
diseas
other
approxim
infect
present
common
complaint
upper
respiratori
tract
infect
gastrointestin
complaint
flulik
ill
may
go
undiagnos
asept
mening
observ
flaccid
paralyt
symptom
note
infect
patient
infecti
day
symptom
present
polioviru
present
stool
week
exposur
although
polio
erad
us
remain
threat
part
asia
africa
middl
east
recommend
adult
booster
travel
countri
polio
infect
persist
even
person
receiv
full
immun
seri
childhood
person
report
histori
polio
childhood
posttravel
consult
recommend
patient
travel
develop
countri
develop
ill
travel
abroad
soon
return
develop
febril
ill
within
month
return
malariaendem
region
conduct
care
review
itinerari
activ
exposur
make
note
symptom
known
accompani
travelrel
infecti
diseas
common
area
visit
includ
date
symptom
first
appear
progress
remiss
recurr
mani
infecti
diseas
acquir
abroad
initi
present
vagu
nonspecif
complaint
often
overlook
underreport
misdiagnos
tabl
initi
phase
pass
patient
symptom
clinic
statu
may
declin
rapidli
special
test
differenti
infecti
agent
determin
appropri
treatment
done
care
infecti
diseas
id
specialist
np
primari
care
complet
histori
physic
along
baselin
test
complet
blood
count
differenti
complet
metabol
panel
cmp
renal
liver
function
test
appropri
basic
ovum
parasit
stool
test
gastrointestin
symptom
report
tabl
qualifi
laboratori
specif
instruct
provid
order
np
perform
blood
smear
malaria
polymeras
chain
reaction
serolog
test
specif
viral
antigen
well
specif
repeat
stool
test
giardia
cyclospora
referr
qualifi
id
major
medic
center
id
delay
await
return
baselin
test
result
case
suspect
infecti
diseas
acquir
abroad
trigger
immedi
rapid
referr
primari
care
np
attempt
definit
diagnos
manag
infect
without
specialist
intervent
case
infecti
diseas
acquir
intern
diseas
transmit
person
person
local
middl
east
respiratori
syndrom
coronaviru
mer
cov
tuberculosi
measl
polio
typhoid
fever
report
requir
within
municip
state
cdc
intern
travel
increas
global
marketplac
continu
imper
np
work
knowledg
emerg
diseas
pattern
trend
worldwid
